Search - tctmd.com

Displaying 281 - 300 of 387

Sort: Relevancy | Date

Postoperative A-fib Not as Bad as Nonsurgical A-fib for Thromboembolism

News Daily News

Postoperative A-fib Not as Bad as Nonsurgical A-fib for Thromboembolism

March 29, 2018

More Awareness of Familial Hypercholesterolemia and Severe Dyslipidemia, yet Statin Use Remains Low

News Daily News

More Awareness of Familial Hypercholesterolemia and Severe Dyslipidemia, yet Statin Use Remains Low

Yael L. Maxwell

March 28, 2018

US Survey: CHD, Stroke Less Common Among Foreign-Born Adults

News Daily News

US Survey: CHD, Stroke Less Common Among Foreign-Born Adults

March 28, 2018

No Link Between Operator Volume and Post-PCI Mortality in the UK

News Daily News

No Link Between Operator Volume and Post-PCI Mortality in the UK

March 27, 2018

New Surgical Valve Durability Data Set ‘Critical Benchmark’ for TAVR Devices

News Daily News

New Surgical Valve Durability Data Set ‘Critical Benchmark’ for TAVR Devices

Yael L. Maxwell

March 26, 2018

Best Practice for PCI: Lessons from SYNTAX II

Presentation CIT 2018

Best Practice for PCI: Lessons from SYNTAX II

Presenter: Patrick W. Serruys

March 23, 2018

News Industry News

Amgen Receives Positive CHMP Opinion Recognizing That Repatha® (evolocumab) Prevents Heart Attacks And Strokes

March 23, 2018

News Industry News

New Analyses Confirm Patients with Medtronic CRT Devices Experience Less Atrial Fibrillation, Are More Active

March 21, 2018

‘Practical Guide’ for NOACs Gets an Update

News Daily News

‘Practical Guide’ for NOACs Gets an Update

March 20, 2018

High CRP Linked to Bigger Absolute Drops in CV Events for Patients Taking Evolocumab

News Conference News ACC 2018

High CRP Linked to Bigger Absolute Drops in CV Events for Patients Taking Evolocumab

Michael O'Riordan

March 20, 2018

Urgent/Emergent TAVR: Risky but Rewarding, TVT Registry Data Hint

News Conference News ACC 2018

Urgent/Emergent TAVR: Risky but Rewarding, TVT Registry Data Hint

March 19, 2018

CANVAS Analysis Provides Heart Failure Reassurances for Canagliflozin

News Conference News

CANVAS Analysis Provides Heart Failure Reassurances for Canagliflozin

Michael O'Riordan

March 16, 2018

Newest HeartMate 3 LV Assist Device Slashes Thrombosis, Reoperation Rates in Advanced HF: MOMENTUM 3

News Conference News ACC 2018

Newest HeartMate 3 LV Assist Device Slashes Thrombosis, Reoperation Rates in Advanced HF: MOMENTUM 3

March 16, 2018

Perioperative Beta-blockade for Noncardiac Surgery Increases Death, Stroke at 1 Year

News Conference News ACC 2018

Perioperative Beta-blockade for Noncardiac Surgery Increases Death, Stroke at 1 Year

Yael L. Maxwell

March 15, 2018

PFO Closure Guided by High-Risk Features on Echo Shows Benefit in DEFENSE-PFO

News Conference News ACC 2018

PFO Closure Guided by High-Risk Features on Echo Shows Benefit in DEFENSE-PFO

March 15, 2018

PHARMCLO: Biggest Genotyping Trial to Date Suggests Better Outcomes After ACS, With Caveats

News Conference News ACC 2018

PHARMCLO: Biggest Genotyping Trial to Date Suggests Better Outcomes After ACS, With Caveats

Yael L. Maxwell

March 14, 2018

Precision Medicine Gamble Fails for CETP Inhibitors in ACCELERATE Analysis

News Conference News ACC 2018

Precision Medicine Gamble Fails for CETP Inhibitors in ACCELERATE Analysis

Michael O'Riordan

March 14, 2018

Gout Drug Febuxostat Linked to More CV Deaths Without Uptick in CV Events: CARES Trial

News Conference News ACC 2018

Gout Drug Febuxostat Linked to More CV Deaths Without Uptick in CV Events: CARES Trial

March 14, 2018

No Increased Risk of Serious Liver Injury Seen With NOACs

News Daily News

No Increased Risk of Serious Liver Injury Seen With NOACs

March 13, 2018

Reversal Agent for Factor Xa Inhibitors Continues to Look Good: ANNEXA-4

News Conference News ACC 2018

Reversal Agent for Factor Xa Inhibitors Continues to Look Good: ANNEXA-4

March 13, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.